Cargando…
Variant lambda of the severe acute respiratory syndrome coronavirus 2: A serious threat or the beginning of further dangerous mutations
Autores principales: | Szarpak, Lukasz, Savytskyi, Ivan, Pruc, Michal, Gozhenko, Anatolyi, Filipiak, Krzysztof J., Rafique, Zubaid, Peacock, Frank W., Ilesanmi, Olayinka S., Chirico, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890414/ https://www.ncbi.nlm.nih.gov/pubmed/34642924 http://dx.doi.org/10.5603/CJ.a2021.0121 |
Ejemplares similares
-
Myocarditis: A complication of COVID-19 and long-COVID-19 syndrome as a serious threat in modern cardiology
por: Szarpak, Lukasz, et al.
Publicado: (2022) -
Mucormycosis—A serious threat in the COVID-19 pandemic?
por: Szarpak, Lukasz, et al.
Publicado: (2021) -
Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis
por: Szarpak, Luiza, et al.
Publicado: (2022) -
Need to update cardiological guidelines to prevent COVID-19 related myocardial infarction and ischemic stroke
por: Nucera, Gabriella, et al.
Publicado: (2022) -
A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19
por: Szarpak, Luiza, et al.
Publicado: (2021)